ICD-10 Coding for Enlarged Lymph Node(B95.0U, C85.9, C85.9U)
Explore ICD-10 codes for enlarged lymph nodes, including R59.0, R59.1, and I88.9. Learn about documentation requirements and coding pitfalls.
Complete code families applicable to Enlarged Lymph Node
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| R59.0 | Localized enlarged lymph nodes | Use when lymphadenopathy is confined to a single region and no underlying cause is identified. |
|
| R59.1 | Generalized enlarged lymph nodes | Use when lymphadenopathy is present in two or more non-contiguous regions. |
|
| R59.9 | Enlarged lymph nodes, unspecified | Use only when no specific location or cause is documented. |
|
| I88.9 | Nonspecific lymphadenitis | Use when inflammation of lymph nodes is confirmed. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutEnlarged Lymph Node
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Enlarged Lymph Node.
Failing to document underlying condition
Impact
Clinical: Inaccurate clinical picture and treatment plan, Regulatory: Non-compliance with coding guidelines, Financial: Potential for denied claims or reduced reimbursement
Mitigation
Always assess and document potential underlying causes, Use additional codes for confirmed conditions
Using R59.9 when location is documented
Impact
Reimbursement: Reduced reimbursement due to lack of specificity, Compliance: Non-compliance with coding guidelines, Data Quality: Poor data quality and inaccurate clinical records
Mitigation
Specify R59.0 or R59.1 with exact site
Sequencing lymphoma as secondary
Impact
Reimbursement: Incorrect DRG assignment affecting reimbursement, Compliance: Violation of sequencing rules, Data Quality: Misleading clinical data regarding treatment focus
Mitigation
Code lymphoma first if treatment is directed at cancer
Use of unspecified codes
Impact
Frequent use of R59.9 can trigger audits due to lack of specificity.
Mitigation
Encourage detailed documentation and use of specific codes.